|
CA2231509C
(en)
*
|
1995-09-11 |
2008-07-08 |
Osteoarthritis Sciences, Inc. |
Protein tyrosine kinase inhibitors for treating osteoarthritis
|
|
IL119069A0
(en)
|
1996-08-14 |
1996-11-14 |
Mor Research Applic Ltd |
Pharmaceutical composition comprising tyrphostins
|
|
DE19845372A1
(de)
*
|
1998-10-02 |
2000-04-20 |
Gruenenthal Gmbh |
Verwendung von Katecholderivaten als Proteinaseninhibitoren
|
|
ES2301255T3
(es)
|
1998-12-17 |
2008-06-16 |
F. Hoffmann-La Roche Ag |
4,5-pirazinaxindoles como inhibidores de proteinoquinasas.
|
|
DE69906152T2
(de)
|
1998-12-17 |
2004-02-12 |
F. Hoffmann-La Roche Ag |
4-alkenyl (und alkinyl)oxoindole als inhibitoren cyclinabhängiger kinasen, insbesondere cdk2
|
|
KR20010101266A
(ko)
|
1998-12-17 |
2001-11-14 |
프리돌린 클라우스너, 롤란드 비. 보레르 |
Ｊｎｋ 단백질 키나제의 억제제로서의 4-아릴옥신돌
|
|
US6153634A
(en)
|
1998-12-17 |
2000-11-28 |
Hoffmann-La Roche Inc. |
4,5-azolo-oxindoles
|
|
EP1147214B1
(en)
|
1999-01-13 |
2011-01-05 |
The Research Foundation Of State University Of New York |
A novel method for designing protein kinase inhibitors
|
|
US7070936B1
(en)
|
1999-01-13 |
2006-07-04 |
The Research Foundation Of State University Of New York |
Method for designing protein kinase inhibitors
|
|
CN1402642A
(zh)
*
|
1999-07-21 |
2003-03-12 |
奥默罗斯公司 |
用于抑制疼痛,炎症和软骨退化的溶液及方法
|
|
US6313310B1
(en)
|
1999-12-15 |
2001-11-06 |
Hoffmann-La Roche Inc. |
4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
|
|
EP1875900A3
(en)
*
|
2000-01-24 |
2010-07-21 |
Genzyme Corporation |
JAK/STAT pathway inhibitors and the use thereof for the treatment of osteoarthritis
|
|
AU2968701A
(en)
*
|
2000-01-24 |
2001-07-31 |
Genzyme Corporation |
Jak/stat pathway inhibitors and the uses thereof
|
|
CA2404919A1
(en)
*
|
2000-04-06 |
2002-10-01 |
Kyowa Hakko Kogyo Co. Ltd. |
Diagnostic and therapeutic agents for rheumatoid arthritis
|
|
WO2002035987A2
(en)
*
|
2000-11-03 |
2002-05-10 |
Massachusetts Institute Of Technology |
METHODS FOR IDENTIFYING TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE CAUSED BY β-AMYLOID PEPTIDES
|
|
US7067550B2
(en)
*
|
2000-11-03 |
2006-06-27 |
Massachusetts Institute Of Technology |
Treatments for neurotoxicity in Alzheimer's Disease
|
|
US7132427B2
(en)
|
2001-06-21 |
2006-11-07 |
Ariad Pharmaceuticals, Inc. |
Quinazolines and uses thereof
|
|
JP4623962B2
(ja)
*
|
2001-10-22 |
2011-02-02 |
ザ・リサーチ・ファウンデーション・オブ・ステイト・ユニバーシティ・オブ・ニューヨーク |
タンパク質キナーゼおよびホスファターゼ阻害剤、それらを設計する方法、ならびにそれらを使用する方法
|
|
US7005445B2
(en)
*
|
2001-10-22 |
2006-02-28 |
The Research Foundation Of State University Of New York |
Protein kinase and phosphatase inhibitors and methods for designing them
|
|
AU2003217982A1
(en)
*
|
2002-03-06 |
2003-09-22 |
The Medical Research And Education Trust |
Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol
|
|
US6924285B2
(en)
|
2002-03-30 |
2005-08-02 |
Boehringer Ingelheim Pharma Gmbh & Co. |
Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
|
|
GB0309850D0
(en)
|
2003-04-30 |
2003-06-04 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
US20080145840A1
(en)
*
|
2003-06-30 |
2008-06-19 |
Astrazeneca Ab |
Isothermal Titration Calorimetry Assays
|
|
GB0326459D0
(en)
|
2003-11-13 |
2003-12-17 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
US20090226552A1
(en)
*
|
2004-07-22 |
2009-09-10 |
Colorado State University Research Foundation |
Agents and methods for diagnosing osteoarthritis
|
|
US8697139B2
(en)
|
2004-09-21 |
2014-04-15 |
Frank M. Phillips |
Method of intervertebral disc treatment using articular chondrocyte cells
|
|
ATE501148T1
(de)
|
2004-12-14 |
2011-03-15 |
Astrazeneca Ab |
Pyrazolopyrimidinverbindungen als antitumormittel
|
|
DE102005005274A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Peter Heger |
Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Prävention und Behandlung chronisch-entzündlicher Erkrankungen
|
|
ES2354457T3
(es)
|
2005-09-20 |
2011-03-15 |
Astrazeneca Ab |
Compuestos de 4-(1h-indazol-5-il-amino)-quinazolina como inhibidores del receptor erbb de la tirosina quinasa para el tratamiento del cáncer.
|
|
US8133867B2
(en)
*
|
2006-03-20 |
2012-03-13 |
Seikagaku Corporation |
Method for treating rheumatoid arthritis with an antibody that binds to a hepatocyte growth factor receptor
|
|
US7838542B2
(en)
*
|
2006-06-29 |
2010-11-23 |
Kinex Pharmaceuticals, Llc |
Bicyclic compositions and methods for modulating a kinase cascade
|
|
EP1921070A1
(de)
|
2006-11-10 |
2008-05-14 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
|
|
JP5377332B2
(ja)
|
2007-02-06 |
2013-12-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
二環式へテロ環、それらの化合物を含む薬剤、その使用及びその製法
|
|
WO2009026705A1
(en)
*
|
2007-08-24 |
2009-03-05 |
The University Of Western Ontario |
Method of diagnosing and treating osteoarthritis
|
|
WO2009098061A1
(de)
|
2008-02-07 |
2009-08-13 |
Boehringer Ingelheim International Gmbh |
Spirocyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
MX2010012442A
(es)
|
2008-05-13 |
2011-10-11 |
Astrazeneca Ab |
Sal de fumarato de 4-(3-cloro-2-fluoroanilino)-7-metoxi-6-{[1-(n-m etilcarbamoilmetil) piperidin-4-il]oxi}quinazolina.
|
|
CN101396369B
(zh)
*
|
2008-08-07 |
2010-12-01 |
杜宁 |
槐角苷的制药应用
|
|
EP2313397B1
(de)
|
2008-08-08 |
2016-04-20 |
Boehringer Ingelheim International GmbH |
Cyclohexyloxy-substituierte heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|